Equity |
12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||
| Equity [Abstract] | |||||||||||||
| Equity |
Note 13.- Equity
As of December 31, 2021, the share capital of the Company amounts to $11,240,297 ($10,667,087 as of December 31, 2020)
represented by 112,402,973 ordinary shares (106,670,866 shares as of December 31, 2020) fully subscribed and disbursed with a nominal value of $0.10
each, all in the same class and series. Each share grants one voting right.
Algonquin owns 43.6% of the
shares of the Company and is its largest shareholder as of December 31,2021.
On December 11, 2020 the Company closed an underwritten public offering of 5,069,200 ordinary shares, including 661,200 ordinary
shares sold pursuant to the full exercise of the underwriters’ over-allotment option, at a price of $33 per new share. Gross
proceeds were approximately $167 million. Given that the offering was issued through a subsidiary in Jersey, which became wholly
owned by the Company at closing, and subsequently liquidated, the premium on issuance was credited to a merger reserve account (Capital reserves), net of issuance costs, for $161 million. Additionally, Algonquin committed to purchase 4,020,860
ordinary shares in a private placement in order to maintain its previous equity ownership of 44.2% in the Company. The
private placement closed on January 7, 2021. Gross proceeds were approximately $133 million ($131 million net of issuance costs).
During the first quarter of 2021, the Company changed the accounting treatment applied to its existing long-term incentive plans granted
to employees from cash-settled to equity-settled in accordance with IFRS 2, Share-based Payment, as a result of incentives being settled in shares. The liability recognized for the rights vested by the employees under such plans at the date
of this change, was reclassified to equity within the line “Accumulated deficit” for approximately $9 million. The settlement in
shares was approved by the Board of Directors on February 26, 2021, and the Company issued 141,482 new shares to its employees
up to December 31, 2021, to settle a portion of these plans.
On August 3, 2021, the Company established an “at-the-market program” (the “ATM”) and entered into the distribution agreement with J.P.
Morgan Securities LLC, as sales agent, (the “Distribution Agreement”) under which the Company may offer and sell from time to time up to $150
million of its ordinary shares. The Company also entered into an agreement with Algonquin pursuant to which the Company has offered Algonquin the right but not the obligation, on a quarterly basis, to purchase a number of ordinary shares to
maintain its percentage interest in Atlantica at the average price of the shares sold under the Distribution Agreement in the previous quarter (the “ATM Plan Letter Agreement”). During the year 2021, the Company sold 1,613,079 shares at an average market price of $38.43
pursuant to its Distribution Agreement, representing net proceeds of $61 million. Pursuant to the ATM Plan Letter Agreement, the
Company delivers a notice to Algonquin quarterly in order for them to exercise their rights thereunder.
Atlantica´s reserves as of December 31, 2021 are made up of share premium account and capital reserves. The share premium account reduction by $200 million during the year 2021, increasing capital reserves by the same amount, was made effective upon the confirmation received from the High
Court in the UK, pursuant to the Companies Act 2006.
Other reserves primarily include the change in fair value of cash flow hedges and its tax effect.
Accumulated currency translation differences primarily include the result of translating the financial statements of subsidiaries prepared in a foreign currency
into the presentation currency of the Company, the U.S. dollar.
Accumulated deficit primarily includes results attributable to Atlantica.
Non-controlling interests fully relate to interests held by JGC in Solacor 1 and Solacor 2, by Idae in Seville PV, by Itochu Corporation in
Solaben 2 and Solaben 3, by Algerian Energy Company, SPA and Sacyr Agua S.L. in Skikda , by Algerian Energy Company, SPA in Tenes, by Industrial Development Corporation of South Africa (IDC) and Kaxu Community Trust in Kaxu, by Algonquin
Power Co. in AYES Canada, and by partners of the Company in the Chilean renewable energy platform in Chile PV 1 and Chile PV 2.
Additional information of subsidiaries including material non-controlling interests as of December 31, 2021 and 2020, is disclosed in Appendix IV.
Dividends declared during the year 2021 by the Board of Directors of the Company were:
In addition, the Company declared dividends and distributions to non-controlling interests, primarily to Algonquin (interests in Amherst
through AYES Canada, see Note 7) for $17.3 million in 2021 ($14.7 million in 2020), Algerian Energy Company for $6.6
million in 2021 ($3.7 million in 2020) and Itochu for $5.7 million in 2021 ($1.4 million in 2020).
As of December 31, 2021, there was no
treasury stock and there have been no transactions with treasury stock during the period then ended.
|